Tivozanib + Enzalutamide in Adv Prostate Cancer
Massachusetts General Hospital
Massachusetts General Hospital
Pfizer
Ocellaris Pharma, Inc.
Incyte Corporation
Tempus AI
Incyte Corporation
University of Washington
Pfizer
NuCana plc
Exelixis
NRG Oncology
Saving Patients' Lives Medical B.V.
Elevation Oncology
Indiana University
Incyte Corporation
University of California, San Diego
Pfizer
Cancer Trials Ireland
Pfizer
Pfizer
Hookipa Biotech GmbH
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Leap Therapeutics, Inc.
pharmaand GmbH
SpectronRX
Fred Hutchinson Cancer Center
Nektar Therapeutics
AIO-Studien-gGmbH
Dana-Farber Cancer Institute
Ipsen
InSightec
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
Virginia Commonwealth University
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Icahn School of Medicine at Mount Sinai
Maastricht Radiation Oncology
Eli Lilly and Company
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
The University of Texas Health Science Center, Houston
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Wake Forest University Health Sciences